Journal article

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy

Maciej Tatarczuch, Erin Paul, Michael Gilberston, Gareth P Gregory, Constantine Tam, Quach Hang, Ali Bazargan, Robin Filshie, Matthew Ku, Amanda Tey, Jake Shortt, Stephen Opat

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2021


Primary CNS lymphoma (PCNSL) in immunocompetent patients is a disease of older adults who are often unsuitable for the high dose therapy or experience substantial morbidity from whole brain radiotherapy. As therapeutic studies in older patients are limited, there is a need for real world data to guide patient care. Here we report a series of 38 consecutive immunocompetent patients with PCNSL treated with curative intent using R-MPV/Ara-C with omission of consolidative radiotherapy in older patients. Outcomes for patients aged 60 years were similar with overall response rates of 100% vs 85%, (p = .30), 4-year PFS of 81% vs 82% (p = .92) and 4-year OS of 80% vs 77% (p = .52) respectively. Thi..

View full abstract